Publicaciones en las que colabora con ANGEL SÁNCHEZ RODRÍGUEZ (7)

2012

  1. Osteoprotegerin is associated with cardiovascular risk in hypertension and/or diabetes

    European Journal of Clinical Investigation, Vol. 42, Núm. 5, pp. 548-556

2010

  1. Increased plasma soluble endoglin levels as an indicator of cardiovascular alterations in hypertensive and diabetic patients

    BMC Medicine, Vol. 8

2009

  1. Effect of different antihypertensive treatments on Ras, MAPK and Akt activation in hypertension and diabetes

    Clinical Science, Vol. 116, Núm. 2, pp. 165-173

2008

  1. Identification of serum endoglin as a novel prognostic marker after acute myocardial infarction: Molecular Diagnosis

    Journal of Cellular and Molecular Medicine, Vol. 12, Núm. 3, pp. 955-961

2001

  1. Endoglin expression in human and rat mesangial cells and its upregulation by TGF-β1

    Biochemical and Biophysical Research Communications, Vol. 282, Núm. 1, pp. 142-147

1999

  1. Effects of chronic nitric oxide activation or inhibition on early hepatic fibrosis in rats with bile duct ligation

    Clinical Science, Vol. 96, Núm. 3, pp. 297-305

1997

  1. Elevated glomerular and blood mononuclear lymphocyte nitric oxide production in rats with chronic bile duct ligation: Role of inducible nitric oxide synthase activation

    Hepatology, Vol. 26, Núm. 2, pp. 268-276